Sanguinarine-Chelerythrine Fraction of Exerts Anti-inflammatory Activity in Carrageenan Paw Oedema Test in Rats and Reveals Reduced Gastrotoxicity
Overview
Endocrinology
Authors
Affiliations
Inflammatory diseases are a common therapeutic problem and nonsteroidal anti-inflammatory drugs are not deprived of side effects, of which ulcerogenic activity is one of the most frequent. The aim of the study was to evaluate the anti-inflammatory activity of the sanguinarine-chelerythrine (SC) fraction of and its influence on the integrity of gastric mucosa. The study was conducted on sixty male rats randomly divided into six experimental groups: two control groups (a negative control group CON and a positive control group CAR); three groups receiving an investigational fraction of (1, 5, 10 mg/kg ) named SC, SC, and SC, respectively; and a group receiving indomethacin (IND) (10 mg/kg ) as a reference drug. In all animals, the carrageenan-induced paw oedema was measured; PGE release, TNF production, and MMP-9 concentration in inflamed tissue were determined. Additionally, the macroscopic and microscopic damage of gastric mucosa was evaluated. Administration of SC dose-dependently inhibited the second phase of carrageenan rat paw oedema and PGE release, decreased the production of TNF, and reduced the concentration of MMP-9, and the efficacy of the highest dose was comparable to the effect of IND. Contrary to IND, no gastrotoxic activity of SC was detected. The investigated sanguinarine-chelerythrine fraction of seems to be a promising candidate for further research on new anti-inflammatory and analgesic drugs characterized with a safer gastric profile compared to existing NSAIDs.
Meng Y, Si Y, Guo T, Zhao W, Zhang L, Wang Y Sci Rep. 2025; 15(1):6642.
PMID: 39994297 PMC: 11850888. DOI: 10.1038/s41598-025-91251-1.
Recent Advances in Alkaloids from in China: Structural Characteristics and Pharmacological Effects.
Zhang M, Yang J, Sun Y, Kuang H Molecules. 2024; 29(16).
PMID: 39202856 PMC: 11357172. DOI: 10.3390/molecules29163778.
Identification of Sanguinarine Metabolites in Rats Using UPLC-Q-TOF-MS/MS.
Liu M, Liu Z, Dong Z, Zou X, Zeng J, Yang Z Molecules. 2023; 28(22).
PMID: 38005364 PMC: 10674372. DOI: 10.3390/molecules28227641.
Yue M, Huang J, Ma X, Huang P, Liu Y, Zeng J Molecules. 2023; 28(13).
PMID: 37446938 PMC: 10343248. DOI: 10.3390/molecules28135277.
Yang Y, Lu W, Zhang X, Wu C Front Pharmacol. 2022; 13:1032919.
PMID: 36467054 PMC: 9716107. DOI: 10.3389/fphar.2022.1032919.